๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-01

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma (NCT06517888)

A Phase 1/2 Trial of AAVAnc80-antiVEGF Gene Therapy in Individuals With Unilateral Vestibular Schwannoma

๐ŸŸข Recruiting Phase1 / Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Akouos, Inc.

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This trial will evaluate the safety and tolerability of a single unilateral administration of one of three dose levels of AAVAnc80-antiVEGF and will evaluate the Akouos delivery device to safely achieve the intended product performance.

Who can join: Review the eligibility criteria below.

Location: Johns Hopkins Hospital โ€” Baltimore, Maryland

Age range: 18 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (4 Sites)

  • Johns Hopkins Hospital โ€” Baltimore, Maryland
  • Mayo Clinic โ€” Rochester, Minnesota
  • Vanderbilt Bill Wilkerson Center โ€” Nashville, Tennessee
  • University of Texas Southwestern โ€” Dallas, Texas

๐Ÿ“ž Contact the Study Coordinator

Phone: (857) 410-1816

Email: AkouosClinicalTrials@Lilly.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—